Compass Capital Management Inc. Increases Holdings in Stryker Co. (NYSE:SYK)

Compass Capital Management Inc. grew its holdings in shares of Stryker Co. (NYSE:SYK) by 0.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 185,074 shares of the medical technology company’s stock after buying an additional 65 shares during the period. Stryker accounts for about 3.9% of Compass Capital Management Inc.’s holdings, making the stock its 15th largest holding. Compass Capital Management Inc.’s holdings in Stryker were worth $55,422,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the business. Linden Thomas Advisory Services LLC increased its position in shares of Stryker by 6.9% during the third quarter. Linden Thomas Advisory Services LLC now owns 2,915 shares of the medical technology company’s stock worth $797,000 after purchasing an additional 188 shares in the last quarter. Avestar Capital LLC increased its position in shares of Stryker by 17.0% during the third quarter. Avestar Capital LLC now owns 1,116 shares of the medical technology company’s stock worth $305,000 after purchasing an additional 162 shares in the last quarter. Brookstone Capital Management increased its position in shares of Stryker by 6.9% during the third quarter. Brookstone Capital Management now owns 8,022 shares of the medical technology company’s stock worth $2,153,000 after purchasing an additional 521 shares in the last quarter. PDS Planning Inc increased its position in shares of Stryker by 3.0% during the third quarter. PDS Planning Inc now owns 1,318 shares of the medical technology company’s stock worth $360,000 after purchasing an additional 38 shares in the last quarter. Finally, Copeland Capital Management LLC increased its position in shares of Stryker by 16.6% during the third quarter. Copeland Capital Management LLC now owns 11,889 shares of the medical technology company’s stock worth $3,249,000 after purchasing an additional 1,694 shares in the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 201,146 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the completion of the sale, the director now directly owns 3,755,128 shares in the company, valued at approximately $1,287,633,391.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, CAO William E. Berry, Jr. sold 7,690 shares of the stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the sale, the chief accounting officer now directly owns 3,675 shares in the company, valued at approximately $1,317,414. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 201,146 shares of the stock in a transaction on Monday, February 5th. The shares were sold at an average price of $342.90, for a total value of $68,972,963.40. Following the completion of the sale, the director now owns 3,755,128 shares of the company’s stock, valued at $1,287,633,391.20. The disclosure for this sale can be found here. Insiders sold a total of 212,109 shares of company stock worth $72,845,768 in the last ninety days. Insiders own 5.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Evercore ISI lifted their target price on Stryker from $340.00 to $370.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and set a $360.00 price target on the stock in a research report on Wednesday, January 31st. Truist Financial boosted their price target on Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a research report on Wednesday, January 31st. Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and boosted their price target for the company from $315.00 to $360.00 in a research report on Wednesday, January 31st. Finally, Citigroup boosted their price target on Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $340.67.

Stryker Trading Down 0.7 %

SYK traded down $2.37 during trading on Tuesday, hitting $336.50. The company’s stock had a trading volume of 2,459,598 shares, compared to its average volume of 1,301,242. The firm’s 50 day moving average price is $348.68 and its 200-day moving average price is $316.14. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.97. The stock has a market cap of $128.03 billion, a PE ratio of 41.09, a PEG ratio of 2.70 and a beta of 0.89. Stryker Co. has a twelve month low of $249.98 and a twelve month high of $361.41.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, beating the consensus estimate of $3.27 by $0.19. The company had revenue of $5.82 billion during the quarter, compared to the consensus estimate of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. Stryker’s revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the firm posted $3.00 EPS. On average, analysts expect that Stryker Co. will post 11.86 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Friday, March 29th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.95%. Stryker’s payout ratio is 38.79%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.